Product Details for ANDA 076719
AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)
EQ 2.5MG BASE
Marketing Status: Prescription
EQ 5MG BASE
Marketing Status: Prescription
EQ 10MG BASE
Marketing Status: Prescription
EQ 2.5MG BASE
Marketing Status: Prescription
Active Ingredient: AMLODIPINE BESYLATE
Proprietary Name: AMLODIPINE BESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076719
Product Number: 001
Approval Date: May 23, 2007
Applicant Holder Full Name: COREPHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)
Proprietary Name: AMLODIPINE BESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076719
Product Number: 001
Approval Date: May 23, 2007
Applicant Holder Full Name: COREPHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 5MG BASE
Marketing Status: Prescription
Active Ingredient: AMLODIPINE BESYLATE
Proprietary Name: AMLODIPINE BESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076719
Product Number: 002
Approval Date: May 23, 2007
Applicant Holder Full Name: COREPHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)
Proprietary Name: AMLODIPINE BESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076719
Product Number: 002
Approval Date: May 23, 2007
Applicant Holder Full Name: COREPHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 10MG BASE
Marketing Status: Prescription
Active Ingredient: AMLODIPINE BESYLATE
Proprietary Name: AMLODIPINE BESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076719
Product Number: 003
Approval Date: May 23, 2007
Applicant Holder Full Name: COREPHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: AMLODIPINE BESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076719
Product Number: 003
Approval Date: May 23, 2007
Applicant Holder Full Name: COREPHARMA LLC
Marketing Status: Prescription
Patent and Exclusivity Information